We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Estradot 75 estradiol 75 microgram transdermal drug delivery system 8 pack
Section 19A approved medicine
(Approval lapsed) Estradot 75 estradiol 75 microgram transdermal drug delivery system 8 pack
Section 19A approval holder
Novartis Pharmaceuticals Australia Pty Ltd ABN 18 004 244 160
Phone
1800 671 203
Approved until
Status
Expired
Medicines in short supply/unavailable
ESTRADOT 75 estradiol 75 microgram transdermal drug delivery system sachet - ARTG 97565
Indication(s)
Short term oestrogen replacement therapy for the treatment of the symptoms of natural or surgically induced menopause. In women with an intact uterus, oestrogens should always be supplemented by administration of a progestogen.